Orchestra BioMed Holdings, Inc.: Financial Report Shows Revenue Struggles by Terry Bingman 28.03.2024 Orchestra BioMed Holdings, Inc. financial report: Stock closed at $5.00, 52-week range $4.26-$23.39, market cap $188.013M. No dividends. Latest data ...
Slam Corp.: Exploring Potential Merger Opportunities by Mark Eisenberg 27.03.2024 Explore the financial potential of Slam Corp., a shell company in New York seeking merger or acquisition opportunities. Stay informed ...
Bitcoin and Altcoin Surge: VET Leads with 65% Rally by John Darbie 16.02.2024 Bitcoin surged 11% in a strong week, while altcoins rallied even higher. VeChain's VET token skyrocketed by 65%, driven by ...